FMR LLC - Other* at Prime Medicine, Inc.

Issuer-level insider activity

Role
Other*
Issuer symbol
PRME on Nasdaq
Identity 1 identity field
Entity type
Company
Source evidence 1 source field
SEC filing history
Open SEC filing history

No buys or sells have been reported by FMR LLC since 02 Jun 2025

Reported holdings for FMR LLC in Prime Medicine, Inc.

Form 4 holding Other*

Prime Medicine, Inc.

Security class
Common Stock
Shares / value
4,228,589
Estimated value
$63,306,629
Report date
24 Oct 2022
Price
$14.97
Ownership
Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned
Form 4 holding Other*

Prime Medicine, Inc.

Security class
Common Stock
Shares / value
4,124,375
Estimated value
$61,746,431
Report date
24 Oct 2022
Price
$14.97
Ownership
F-Prime Capital Partners Life Sciences Fund VI LP
Form 4 holding Other*

Prime Medicine, Inc.

Security class
Common Stock
Shares / value
109,982
Estimated value
$1,646,552
Report date
24 Oct 2022
Price
$14.97
Ownership
F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Form 4 holding Other*

Prime Medicine, Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
24 Oct 2022
Price
Ownership
Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned
Underlying class
Common Stock
Underlying amount
Form 4 holding Other*

Prime Medicine, Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
24 Oct 2022
Price
Ownership
F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Other*

Prime Medicine, Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
24 Oct 2022
Price
Ownership
F-Prime Capital Partners Life Sciences Fund VI LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Other*

Prime Medicine, Inc.

Security class
Series B Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
24 Oct 2022
Price
Ownership
Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned
Underlying class
Common Stock
Underlying amount
Form 4 holding Other*

Prime Medicine, Inc.

Security class
Series B Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
24 Oct 2022
Price
Ownership
F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Underlying class
Common Stock
Underlying amount

Transaction history for FMR LLC in Prime Medicine, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .